Matches in SemOpenAlex for { <https://semopenalex.org/work/W3092100350> ?p ?o ?g. }
- W3092100350 endingPage "407" @default.
- W3092100350 startingPage "393" @default.
- W3092100350 abstract "Abstract Cytomegalovirus (CMV)‐based vaccines show promising effects against chronic infections in nonhuman primates. Therefore, we examined the potential of hepatitis B virus (HBV) vaccines based on mouse CMV (MCMV) vectors expressing the small HBsAg. Immunological consequences of vaccine virus attenuation were addressed by either replacing the dispensable gene m157 (“MCMV‐HBsȍ) or the gene M27 (“ΔM27‐HBs”), the latter encodes a potent IFN antagonist targeting the transcription factor STAT2. M27 was chosen, since human CMV encodes an analogous gene product, which also induced proteasomal STAT2 degradation by exploiting Cullin RING ubiquitin ligases. Vaccinated mice were challenged with HBV through hydrodynamic injection. MCMV‐HBs and ΔM27‐HBs vaccination achieved accelerated HBV clearance in serum and liver as well as robust HBV‐specific CD8 + T‐cell responses. When we explored the therapeutic potential of MCMV‐based vaccines, especially the combination of ΔM27‐HBs prime and DNA boost vaccination resulted in increased intrahepatic HBs‐specific CD8 + T‐cell responses and HBV clearance in persistently infected mice. Our results demonstrated that vaccines based on a replication competent MCMV attenuated through the deletion of an IFN antagonist targeting STAT2 elicit robust anti‐HBV immune responses and mediate HBV clearance in mice in prophylactic and therapeutic immunization regimes." @default.
- W3092100350 created "2020-10-15" @default.
- W3092100350 creator A5000393352 @default.
- W3092100350 creator A5011444070 @default.
- W3092100350 creator A5011694968 @default.
- W3092100350 creator A5013341380 @default.
- W3092100350 creator A5016243200 @default.
- W3092100350 creator A5033946832 @default.
- W3092100350 creator A5034482568 @default.
- W3092100350 creator A5038542389 @default.
- W3092100350 creator A5042805169 @default.
- W3092100350 creator A5044836924 @default.
- W3092100350 creator A5063783789 @default.
- W3092100350 creator A5071612651 @default.
- W3092100350 creator A5077930196 @default.
- W3092100350 creator A5081595462 @default.
- W3092100350 date "2020-11-09" @default.
- W3092100350 modified "2023-09-26" @default.
- W3092100350 title "Prophylactic and therapeutic HBV vaccination by an HBs‐expressing cytomegalovirus vector lacking an interferon antagonist in mice" @default.
- W3092100350 cites W1527379503 @default.
- W3092100350 cites W1544333260 @default.
- W3092100350 cites W1608778557 @default.
- W3092100350 cites W1799522345 @default.
- W3092100350 cites W1851333263 @default.
- W3092100350 cites W1918688900 @default.
- W3092100350 cites W1932638060 @default.
- W3092100350 cites W1964110796 @default.
- W3092100350 cites W1980896697 @default.
- W3092100350 cites W1988855972 @default.
- W3092100350 cites W1992349567 @default.
- W3092100350 cites W1993617345 @default.
- W3092100350 cites W1994882633 @default.
- W3092100350 cites W2001137507 @default.
- W3092100350 cites W2003959948 @default.
- W3092100350 cites W2029325372 @default.
- W3092100350 cites W2031489362 @default.
- W3092100350 cites W2033588661 @default.
- W3092100350 cites W2034879833 @default.
- W3092100350 cites W2036402301 @default.
- W3092100350 cites W2039505178 @default.
- W3092100350 cites W2040977485 @default.
- W3092100350 cites W2041919004 @default.
- W3092100350 cites W2047049757 @default.
- W3092100350 cites W2059384462 @default.
- W3092100350 cites W2071267501 @default.
- W3092100350 cites W2075345074 @default.
- W3092100350 cites W2076195337 @default.
- W3092100350 cites W2078830568 @default.
- W3092100350 cites W2087932916 @default.
- W3092100350 cites W2091054183 @default.
- W3092100350 cites W2091957091 @default.
- W3092100350 cites W2092015380 @default.
- W3092100350 cites W2097691794 @default.
- W3092100350 cites W2098459535 @default.
- W3092100350 cites W2099375666 @default.
- W3092100350 cites W2100070721 @default.
- W3092100350 cites W2103849595 @default.
- W3092100350 cites W2111629931 @default.
- W3092100350 cites W2113597524 @default.
- W3092100350 cites W2116968044 @default.
- W3092100350 cites W2122445103 @default.
- W3092100350 cites W2125128634 @default.
- W3092100350 cites W2131674674 @default.
- W3092100350 cites W2136749452 @default.
- W3092100350 cites W2142280910 @default.
- W3092100350 cites W2144723277 @default.
- W3092100350 cites W2158154689 @default.
- W3092100350 cites W2159563923 @default.
- W3092100350 cites W2161071827 @default.
- W3092100350 cites W2162632202 @default.
- W3092100350 cites W2234448540 @default.
- W3092100350 cites W2301170316 @default.
- W3092100350 cites W2347294452 @default.
- W3092100350 cites W2601793983 @default.
- W3092100350 cites W2609065752 @default.
- W3092100350 cites W2753409555 @default.
- W3092100350 cites W2783990226 @default.
- W3092100350 cites W2801105435 @default.
- W3092100350 cites W2801569859 @default.
- W3092100350 cites W2899647726 @default.
- W3092100350 cites W2904111212 @default.
- W3092100350 cites W2914322301 @default.
- W3092100350 cites W2923877889 @default.
- W3092100350 cites W2926709258 @default.
- W3092100350 cites W2962464599 @default.
- W3092100350 cites W2982252373 @default.
- W3092100350 cites W2995870603 @default.
- W3092100350 cites W3007877775 @default.
- W3092100350 cites W3149450293 @default.
- W3092100350 cites W4211026375 @default.
- W3092100350 doi "https://doi.org/10.1002/eji.202048780" @default.
- W3092100350 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33029793" @default.
- W3092100350 hasPublicationYear "2020" @default.
- W3092100350 type Work @default.
- W3092100350 sameAs 3092100350 @default.
- W3092100350 citedByCount "4" @default.
- W3092100350 countsByYear W30921003502021 @default.
- W3092100350 countsByYear W30921003502022 @default.